I sold out entirely, mainly due to dodgy market conditions and a little frustration with CUV sp. Maybe a foolish move, but Neuren is travelling along not too bad. Hoping to jump back over to Clinuvel early next year if conditions are favourable. Clinuvel has a lot on its plate coming up with XP and AIS so I expect lots of potential medium term. Investors have the luxury of two attractive biotechs to choose from in Neuren and CUV so a bet each way wouldn’t go astray either. It will come down to timing for me whether I can capitalise on both early next year.
CUV Charting, page-87
Add CUV (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$15.19 |
Change
-0.060(0.39%) |
Mkt cap ! $765.6M | |||
| Open | High | Low | Value | Volume |
| $15.19 | $15.46 | $15.18 | $175.0K | 11.45K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 3 | 347 | $15.18 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $15.21 | 3 | 1 |
View Market Depth
| Last trade - 12.10pm 23/07/2024 (20 minute delay) ? |
| CUV (ASX) Chart |